Asset Management One Co. Ltd. Purchases 11,320 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Asset Management One Co. Ltd. boosted its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 15.2% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 85,567 shares of the medical device company's stock after buying an additional 11,320 shares during the period. Asset Management One Co. Ltd.'s holdings in Cooper Companies were worth $7,218,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD grew its holdings in shares of Cooper Companies by 517.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company's stock valued at $324,466,000 after buying an additional 2,957,421 shares in the last quarter. Norges Bank acquired a new stake in Cooper Companies during the 4th quarter worth about $217,906,000. FMR LLC boosted its position in Cooper Companies by 97.6% during the 4th quarter. FMR LLC now owns 2,218,112 shares of the medical device company's stock worth $203,911,000 after acquiring an additional 1,095,805 shares during the period. Raymond James Financial Inc. purchased a new position in Cooper Companies during the 4th quarter valued at about $64,826,000. Finally, Victory Capital Management Inc. increased its holdings in shares of Cooper Companies by 14.6% in the 4th quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock valued at $415,985,000 after purchasing an additional 574,899 shares during the period. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Up 2.1%

NASDAQ:COO traded up $1.45 during trading hours on Friday, reaching $71.14. The company's stock had a trading volume of 5,274,900 shares, compared to its average volume of 1,686,861. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.10 and a quick ratio of 1.23. The company has a market cap of $14.23 billion, a price-to-earnings ratio of 34.53, a price-to-earnings-growth ratio of 1.74 and a beta of 0.98. The Cooper Companies, Inc. has a one year low of $65.00 and a one year high of $112.38. The business's 50-day moving average is $76.42 and its 200-day moving average is $84.02.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, topping analysts' consensus estimates of $0.93 by $0.03. The company had revenue of $1 billion during the quarter, compared to analysts' expectations of $995.12 million. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%. The business's quarterly revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.85 earnings per share. Equities research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analysts Set New Price Targets

Several analysts recently commented on COO shares. Piper Sandler restated an "overweight" rating and set a $105.00 price target (down from $115.00) on shares of Cooper Companies in a report on Friday, May 30th. BNP Paribas raised shares of Cooper Companies to a "hold" rating in a research note on Thursday, March 13th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and issued a $76.00 price target (down from $110.00) on shares of Cooper Companies in a research note on Friday, May 30th. Robert W. Baird cut their price objective on Cooper Companies from $107.00 to $97.00 and set an "outperform" rating for the company in a report on Friday, May 30th. Finally, Loop Capital set a $100.00 target price on Cooper Companies in a research note on Tuesday, June 17th. Three analysts have rated the stock with a hold rating and nine have given a buy rating to the company's stock. According to MarketBeat.com, Cooper Companies has an average rating of "Moderate Buy" and a consensus price target of $99.70.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.